Free shipping on all orders over $ 500

Raltegravir

Cat. No. M2595

All AbMole products are for research use only, cannot be used for human consumption.

Raltegravir Structure
Synonym:

MK-0518

Size Price Availability Quantity
5mg USD 68  USD68 In stock
10mg USD 115  USD115 In stock
50mg USD 340  USD340 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Raltegravir (MK-0518) is a novel HIV-1 integrase strand transfer inhibitor with potent in vitro activity against wild-type and multi-class resistant HIV-1 virus (in vitro IC95 for HIV-1 in 50% normal human serum = 33 nM). Raltegravir induces viro-immunological improvement of nonhuman primates with progressing SIVmac251 infection. Raltegravir is administered orally every 12h and does not require boosting with low-dose ritonavir (RTV) to achieve therapeutic concentrations.

Chemical Information
Molecular Weight 444.42
Formula C20H21FN6O5
CAS Number 518048-05-0
Solubility (25°C) DMSO 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Anton Pozniak, et al. Raltegravir in patients with tuberculosis

[2] Rosa de Miguel, et al. A safety evaluation of raltegravir for the treatment of HIV

[3] Emma D Deeks. Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection

[4] Francois Clavel. HIV resistance to raltegravir

[5] F Cossarini, et al. Raltegravir in treatment naive patients

Related Integrase Products
Bictegravir Sodium

Bictegravir (GS-9883) Sodium is a novel and potent inhibitor of HIV-1 integrase, specifically targets IN strand transfer activity with an IC50 of 7.5 nM.

Lavendustin B

Lavendustin B inhibits HIV-1 integrase (IN) interaction with its cognate cellular cofactor lens epithelium-derived growth factor (LEDGF/p75). Lavendustin B is an inhibitor of Tyrosine Kinase and also a competitive inhibitor of glucose transporter 1 (Glut1).

Bictegravir

Bictegravir (GS-9883) is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.

Raltegravir potassium

Raltegravir potassium (MK0518 potassium) is a potent integrase (IN) inhibitor, used to treat HIV infection.

Dolutegravir sodium

Dolutegravir sodium is a potent, second generation HIV integrase inhibitor (IC₅₀ = 2.7 nM) that displays potent antiviral activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Raltegravir, MK-0518 supplier, Integrase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.